Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma-Reference-Cited by-同舟云学术

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Published:2017-10-05 Issue:14 Volume:377 Page:1345-1356
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Wolchok Jedd D.¹,Chiarion-Sileni Vanna¹,Gonzalez Rene¹,Rutkowski Piotr¹,Grob Jean-Jacques¹,Cowey C. Lance¹,Lao Christopher D.¹,Wagstaff John¹,Schadendorf Dirk¹,Ferrucci Pier F.¹,Smylie Michael¹,Dummer Reinhard¹,Hill Andrew¹,Hogg David¹,Haanen John¹,Carlino Matteo S.¹,Bechter Oliver¹,Maio Michele¹,Marquez-Rodas Ivan¹,Guidoboni Massimo¹,McArthur Grant¹,Lebbé Celeste¹,Ascierto Paolo A.¹,Long Georgina V.¹,Cebon Jonathan¹,Sosman Jeffrey¹,Postow Michael A.¹,Callahan Margaret K.¹,Walker Dana¹,Rollin Linda¹,Bhore Rafia¹,Hodi F. Stephen¹,Larkin James¹

Affiliation:

1. From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.),...

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1709684

Cited by 2967 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network-based analysis of heterogeneous patient-matched brain and extracranial melanoma metastasis pairs reveals three homogeneous subgroups;Computational and Structural Biotechnology Journal;2024-12

2. ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer;Neoplasia;2024-11

3. A study on the efficacy and Safety Evaluation of a novel PD-1/CTLA-4 bispecific antibody;Immunobiology;2024-11

4. Targeted Therapy Innovations for Melanoma;Hematology/Oncology Clinics of North America;2024-10

5. Treatment outcomes of vulvar and vaginal melanoma at an NCCN institution between 1993 and 2021;Gynecologic Oncology Reports;2024-10